CEL-SCI CORPORATION (CVM) Net Margin
- 2011-09-30: Net Margin -1346.48%.
- 2011-06-30: Net Margin -4023.43%.
- 2010-06-30: Net Margin -1945.39%.
Complete source-backed net margin history.
- Available history
- 2010-06-30 to 2014-09-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2011-09-30 | -1346.48% |
| 2011-06-30 | -4023.43% |
| 2010-06-30 | -1945.39% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2014-09-30 | -10364.71% |
| 2013-09-30 | -5746.82% |
| 2012-09-30 | -6078.83% |
| 2011-09-30 | -2689.14% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |